DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China
· Delayed Price · Currency is CNY 18.16
-0.25 (-1.36%)
May 13, 2025, 2:45 PM CST
SHA:603233 Revenue
DaShenLin Pharmaceutical Group had revenue of 6.96B CNY in the quarter ending March 31, 2025, with 3.02% growth. This brings the company's revenue in the last twelve months to 26.70B, up 5.38% year-over-year. In the year 2024, DaShenLin Pharmaceutical Group had annual revenue of 26.50B with 8.01% growth.
Revenue (ttm)
26.70B
Revenue Growth
+5.38%
P/S Ratio
0.79
Revenue / Employee
613.36K
Employees
45,466
Market Cap
20.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.50B | 1.97B | 8.01% |
| Dec 31, 2023 | 24.53B | 3.28B | 15.45% |
| Dec 31, 2022 | 21.25B | 4.49B | 26.78% |
| Dec 31, 2021 | 16.76B | 2.18B | 14.92% |
| Dec 31, 2020 | 14.58B | 3.44B | 30.89% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |